Evidence map›Paper›PMID 34316533›Full record

ArticleCurrent developments in nutrition2021

Evaluation of Saccharin and Resveratrol as Extrinsic Markers of Small-Quantity Lipid-Based Nutrient Supplement Consumption in Healthy Women.

Sarah J Zyba, Valerie Weinborn, Charles D Arnold, Arlie L Lehmkuhler, Fanny B Morel, Mamane Zeilani, Alyson E Mitchell, Marjorie J Haskell

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current developments in nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sarah J ZybaInstitute for Global Nutrition, Department of Nutrition, University of California, Davis, Davis, CA, USA.
Valerie WeinbornDepartment of Food Science and Technology, University of California, Davis, Davis, CA, USA.
Charles D ArnoldInstitute for Global Nutrition, Department of Nutrition, University of California, Davis, Davis, CA, USA.
Arlie L LehmkuhlerDepartment of Food Science and Technology, University of California, Davis, Davis, CA, USA.
Fanny B MorelNutriset S.A.S., Malaunay, France.
Mamane ZeilaniNutriset S.A.S., Malaunay, France.
Alyson E MitchellDepartment of Food Science and Technology, University of California, Davis, Davis, CA, USA.
Marjorie J HaskellInstitute for Global Nutrition, Department of Nutrition, University of California, Davis, Davis, CA, USA.
University of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDietary supplements, like small-quantity lipid-based nutrient supplements (SQ-LNS), are used in intervention programs to prevent undernutrition among women and young children in low-income countries. An objective marker is needed to track consumption of supplements to evaluate the effectiveness of these programs.

objectiveThe aim of this study was to evaluate saccharin and resveratrol as potential adherence markers for tracking recent consumption of a single serving of SQ-LNS in women.

methodsForty-seven healthy nonpregnant women 18-45 y of age were assigned to consume a single dose of SQ-LNS (20 g) containing either 10 mg sodium saccharin or 5 mg

resultsForty-five participants were included in the analysis. Urinary concentrations of saccharin and

conclusionsUrinary concentrations of saccharin and

Indexed as

adherence markerresveratrolsaccharinsmall-quantity lipid-based nutrient supplementtrans-resveratrol

Identifiers

PMID34316533
PMCPMC8302444
OpenAlexW3181594229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.